2 4 6 8 15 19 21 22 23 24 26 28 30

Rudolf Bauer Peter Hylands Bruce Robinson (FCPA) Appleby Offshore Incorporations (Cayman) Limited P.O. Box 31119, Grand Pavilion Hibiscus Way, 802 West Bay Road Grand Cayman KY1-1205 Cayman Islands 02 PuraPharm Corporation 2017 Limited 2017 Interim Report

1 4002 183 17 1712 1716 Estera Trust (Cayman) Limited Clifton House, 75 Fort Street P.O. Box 1350 Grand Cayman, KY1-1108 Cayman Islands 1498 500 www.purapharm.com 03

CEPA 62 SODX Co., Ltd.SODX Good Manufacturing PracticeGMP SODXSODX 04 PuraPharm Corporation 2017 Limited 2017 Interim Report

05

CFDA CNASISO17025 70 70%* GMP TGA CNASISO17025 06 PuraPharm Corporation 2017 Limited 2017 Interim Report

07

95,616 36.3% 87,106 41.0% 9.8% 86,772 33.0% 80,329 37.9% 8.0% 34,076 13.0% 22,653 10.7% 50.4% 36,303 13.8% 22,161 10.4% 63.8% 10,326 3.9% 263,093 100.0% 212,249 100.0% 24.0% 263.1 212.2 50.8 24.0% 95.6 87.1 8.59.8% 15.1% 20% 60% 08 PuraPharm Corporation 2017 Limited 2017 Interim Report

86.8 80.3 6.48.0% 36.3 22.2 14.163.8% 3759 CEPA CEPA 09

34.1 22.7 11.450.4% K an Herbs Inc. 9.8 22.7 1.67.0% 10.3 10 PuraPharm Corporation 2017 Limited 2017 Interim Report

263,093 212,249 24.0% 82,225 70,641 16.4% 180,868 141,608 27.7% 68.7% 66.7% 68.7%66.7%2% 7.5 6.9 0.6 8.7% 80.6 65.5 15.123.1%(i) (ii) 30.6%30.9% 11

85.8 66.3 19.529.4%(i) 59 37 (ii)(iii) 3.5 7.0 4.6 2.4 53.2% 4.6 2.1 2.5 121.3% 20.2%33.7% 12 PuraPharm Corporation 2017 Limited 2017 Interim Report

40.535.1 (i)(ii) (iii) 167.6255.8 156.7 209.1 417.7 261.0 537.5 261.0 163.5 197.5 0.570.99 679 544 53.7 53.4 13

* 217,512 84,311 48,582 5,547 8,866 1,419 91,277 274,960 * 190,000,000 217,512,000 288.4 191.5 86.5 30.0% 38.0 72.1 25.0% 54.2 57.7 20.0% 57.7 43.3 15.0% 12.8 28.8 10.0% 28.8 288.4 100.0% 191.5 14 PuraPharm Corporation 2017 Limited 2017 Interim Report

XV352 (1) 141,903,220 (L) (2)(3)(4) 57.29% 1,317,500 (L) 0.53% 51,716,500 (L) (5) 20.82% 300,000 (L) (9) 0.12% 51,566,500 (L) (6) 20.82% 143,520,720 (L) (7) 57.94% 150,000 (L) (9) 0.06% 3,125,000 (L) (8) 1.26% 20,000 (L) (9) 0.01% 150,000 (L) (9) 0.06% 150,000 (L) (9) 0.06% 20,000 (L) (9) 0.01% 20,000 (L) (9) 0.01% 20,000 (L) (9) 0.01% 20,000 (L) (9) 0.01% 15

1. L 2. Joint Partners Investments LimitedJoint Partners50% Joint Partners Purapharm Corporation LimitedPuraPharm Corp. PuraPharm Corp. 51,566,500 PuraPharm Corp. 3. Fullgold Development LimitedFullgold Development Fullgold Development77,286,000Fullgold Development 4. 13,050,720 5. 6. Joint Partners 50%Joint Partners PuraPharm Corp. PuraPharm Corp.51,566,500PuraPharm Corp. 7. 8. Best Revenue Investments LimitedBest RevenueK.M. Chan & Co. LimitedKM Chan Best Revenue KM Chan1,562,500 1,562,500 Best Revenue KM Chan 9. XV 352 16 PuraPharm Corporation 2017 Limited 2017 Interim Report

XV2 3 336 (1) PuraPharm Corp 51,566,500(L) 20.82% Joint Partners 51,566,500(L) (2) 20.82% Fullgold Development 77,286,000(L) 31.20% 13,050,720(L) 5.27% 1. L 2. PuraPharm Corp Joint PartnersJoint Partners PuraPharm Corp 336 XV2 3 22(a) 17

1. 2. 3. 10,000,000 3,021,0003,021,000 2,050,000 300,000 150,000 150,000 150,000 20,000 20,000 20,000 20,000 20,000 1,200,000 2,050,000 157,000 18 PuraPharm Corporation 2017 Limited 2017 Interim Report

A.2.1 A.2.1 3.21C.3 2410 19

SODX Co., Ltd.SODX SODX 244.017.1 SODX SODX SODX www.hkexnews.hk www.purapharm.com 20 PuraPharm Corporation 2017 Limited 2017 Interim Report

22 60 34 34 34 2410 34 21

5 263,093 212,249 (82,225) (70,641) 180,868 141,608 5 7,546 6,943 (80,606) (65,496) (85,790) (66,271) (1,192) (1,804) 7 (7,039) (4,594) 6 13,787 10,386 8 (4,649) (2,101) 9,138 8,285 9,138 8,285 10 4.0 3.7 10 4.0 3.7 22 PuraPharm Corporation 2017 Limited 2017 Interim Report

9,138 8,285 191 174 (32) (29) 159 145 7,970 (4,654) 8,129 (4,509) 17,267 3,776 17,267 3,776 23

11 230,201 117,383 37,895 23,070 30,482 26,470 12 13,951 13,760 17 27,061 8,845 14,341 12,200 13 148,397 502,328 201,728 14 226,127 167,064 15 13,926 16 295,737 231,689 17 53,097 39,638 9,076 11,000 18 156,650 209,129 754,613 658,520 19 71,655 74,191 93,166 58,341 20 417,719 261,048 3,289 7,227 1,160 1,953 586,989 402,760 167,624 255,760 669,952 457,488 24 PuraPharm Corporation 2017 Limited 2017 Interim Report

669,952 457,488 20 119,764 1,903 1,399 2,694 1,584 124,361 2,983 545,591 454,505 21 191,981 174,375 22(b) (10,019) (10,019) 23 363,629 290,149 545,591 454,505 25

21 21 22(b)22(b) 23 23 23 174,375 150,616 (10,019) 1,814 24,685 (7,505) 469 (17,477) 137,547 454,505 9,138 9,138 159 159 7,970 7,970 159 7,970 9,138 17,267 (4,942) (4,942) 24 17,606 60,998 78,604 157 157 191,981 206,672* (10,019) 157* 1,814* 24,685* (7,505)* 628* (9,507)* 146,685* 545,591 * 363,629,000 290,149,000 26 PuraPharm Corporation 2017 Limited 2017 Interim Report

174,375 170,552 1,814 24,685 (7,505) 124 280 105,385 469,710 8,285 8,285 145 145 (4,654) (4,654) 145 (4,654) 8,285 3,776 (19,936) (19,936) (7,375) (7,375) 174,375 170,552 (7,375) 1,814 24,685 (7,505) 269 (4,374) 93,734 446,175 27

13,787 10,386 7 7,039 4,594 6 (2,671) 610 6 38 36 6 9,143 6,846 6 294 269 6 1,460 1,110 6 498 241 5 (261) (431) 22(b) 157 29,484 23,661 (15,884) (19,693) (415) (18,452) 5,992 (15,362) (12,453) (23,100) (5,299) (893) (282) (27,707) (24,640) (72,329) (32,714) 261 431 (265) (703) (9,143) (7,289) (81,476) (40,275) 28 PuraPharm Corporation 2017 Limited 2017 Interim Report

(81,476) (40,275) (35,436) (21,632) 62 (5,065) (13,493) 24 (149,618) 1,924 (5,000) (188,133) (40,125) 382,080 227,714 (143,566) (113,725) (12,285) (7,039) (4,594) 22(b) (7,375) 9 (4,942) (19,936) 214,248 82,084 (55,361) 1,684 209,129 232,243 2,882 (1,383) 156,650 232,544 18 156,650 232,544 29

1. 22 P.O. Box 31119, Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman KY1-1205, Cayman Islands 24 Fullgold Development Limited Fullgold Development Limited 2. 34 30 PuraPharm Corporation 2017 Limited 2017 Interim Report

2. (i)(ii) (iii)(i)(ii) (iii) 31

3. 7 12 12 4. (a) (b) (c) (d) (e) 32 PuraPharm Corporation 2017 Limited 2017 Interim Report

4. 95,616 86,772 34,076 36,303 10,326 263,093 61,249 6,599 1,132 1,213 (70,193) 156,865 93,371 35,208 36,303 11,539 (70,193) 263,093 16,594 24,146 1,038 (1,116) 962 41,624 3,415 261 2,671 (7,039) (27,145) 13,787 (4,649) 9,138 5,706 1,307 821 2,806 257 10,897 498 498 33

4. 87,106 80,329 22,653 22,161 212,249 51,875 4,607 1,121 (57,603) 138,981 84,936 23,774 22,161 (57,603) 212,249 15,042 23,276 266 (4,925) 33,659 4,969 431 (610) (4,594) (23,469) 10,386 (2,101) 8,285 4,552 1,191 941 1,541 8,225 241 241 34 PuraPharm Corporation 2017 Limited 2017 Interim Report

5. 243,026 206,592 9,741 5,657 10,326 263,093 212,249 * 3,415 4,969 2,671 1,107 1,319 261 431 92 224 7,546 6,943 * 35

6. 77,581 67,862 4,644 2,779 9,143 6,846 1,460 1,110 294 269 * 9,083 8,213 77 331 16,020 9,113 16,097 9,444 1,303 1,163 46,981 47,974 6,667 5,419 98 53,746 53,393 ** (2,671) 610 *** 498 241 38 36 * 307,000 323,0004,563,000 4,137,000 ** *** 36 PuraPharm Corporation 2017 Limited 2017 Interim Report

7. 7,039 4,594 8. 16.5% 40% 25% 15% 4,859 2,667 (210) (566) 4,649 2,101 37

9. 2.02 8.89 22(b) 62,00067,000 4,942,00019,936,000 10. (a) 22(b) 9,138 8,285 231,141,476 224,700,846 4.0 3.7 38 PuraPharm Corporation 2017 Limited 2017 Interim Report

10. (b) 9,138 8,285 231,141,476 224,700,846 22(b) 169,890 231,311,366 224,700,846 4.0 3.7 11. 20,701,000 20,770,000 97,682,00099,000 36,000 39

12. 13,951 13,760 3 13. 24 148,397 148,397 40 PuraPharm Corporation 2017 Limited 2017 Interim Report

13. 134,692 13,705 148,397 2.5% 18% 2.3% 15% 41

13. 14. 39,222 64,358 40,501 24,945 148,164 80,270 227,887 169,573 (1,760) (2,509) 226,127 167,064 42 PuraPharm Corporation 2017 Limited 2017 Interim Report

15. 24 13,243 683 13,926 (i) (ii) (iii) (iv) (v) 18% 43

15. 16. 297,063 234,652 3,328 1,554 300,391 236,206 (4,654) (4,517) 295,737 231,689 44 PuraPharm Corporation 2017 Limited 2017 Interim Report

16. 1 58,230 124,199 1 3 65,918 42,690 3 6 40,781 24,841 6 130,808 39,959 295,737 231,689 17. 55,681 26,919 2,339 6,826 22,381 14,973 80,401 48,718 (243) (235) 80,158 48,483 (27,061) (8,845) 53,097 39,638 45

18. 51,477 21,782 72,839 167,095 21,105 14,691 2,947 3,158 2,658 2,403 5,624 156,650 209,129 19. 1 26,233 35,736 1 2 14,386 22,687 2 3 5,715 12,747 3 25,321 3,021 71,655 74,191 46 PuraPharm Corporation 2017 Limited 2017 Interim Report

20. (%) 3.75 5.22 152,433 1.85 6.00 253,199 2.20 2.95 12,087 417,719 2.20 2.95 85,264 8.00 34,500 119,764 537,483 (%) 2.70 5.22 109,270 1.90 6.00 151,778 261,048 47

20. 417,719 261,048 19,898 99,866 537,483 261,048 374,550 166,778 162,933 94,270 537,483 261,048 (a) 5 11,173,000 4,481,000 (b) 666,510,000 458,595,000 502,983,000 261,048,000 48 PuraPharm Corporation 2017 Limited 2017 Interim Report

20. (c) 103,077 54,124 16,550 2,779 2,604 2,570 40,250 39,022 76,751 9,076 11,000 21. 248,308 109,495 50,000,000,000 0.10.775 38,750,000 38,750,000 247,717,920225,000,000 0.10.775 191,981 174,375 49

21. 225,000,000 174,375 150,616 324,991 24 22,717,920 17,606 60,998 78,604 (4,942) (4,942) 247,717,920 191,981 206,672 398,653 22. (a) 10%22,500,00030%12 1% 1.00 10 50 PuraPharm Corporation 2017 Limited 2017 Interim Report

22. (a) (a) (b) (c) (b) 1. 2. 3. 10 10,000,000 62,000 67,000 51

22. (b) 3,021,000 3,021,000 18 2,050,000 615,000 2,295 615,000 410,000 1,529 410,000 410,000 1,529 410,000 410,000 1,529 410,000 205,000 765 205,000 2,050,000 7,647 2,050,000 23. 157,000 50% 25% 52 PuraPharm Corporation 2017 Limited 2017 Interim Report

23. 24. K an Herb Company, Inc.Kan100% 5,400,00042,011,000 Kan KanKan 100%100,700,000 115,281,000 78,604,00022,717,920 53

24. Kan 3,493 94,189 362 14,510 1,514 1,330 22,890 19,301 21,225 13,243 2,794 38,230 5,031 2,643 (1,056) (18,424) (26) (1,268) (96,208) (34,344) (637) (1,293) 28,306 59,193 13,705 134,692 42,011 193,885 42,011 115,281 78,604 42,011 193,885 Kan 22,717,920 3.46 54 PuraPharm Corporation 2017 Limited 2017 Interim Report

24. 41,024,00011,668,000 41,024,00011,668,000 3.5 362,000 Kan () () () (42,011) (115,281) (157,292) 5,031 2,643 7,674 (36,980) (112,638) (149,618) Kan 9,787,00010,326,000 47,000880,000 279,861,000 8,147,000 55

25. 20 26,948 17,849 20,232 20,496 6,186 53,366 38,345 26. 25 * 217,512 84,311 48,582 5,547 8,866 1,419 91,277 274,960 * 190,000,000 217,512,000 56 PuraPharm Corporation 2017 Limited 2017 Interim Report

27. (a) Edtoma Corporate Services Limited Gateway (Macao Commercial Offshore) Company Limited * * * 100% 57

27. (b) (i) 781 (ii) 8,561 (iii) 462 6,824 (iv) 328 371 (v) 193,885 (i) (ii) (iii) 100% (iv) (v) 193,885,000 24 58 PuraPharm Corporation 2017 Limited 2017 Interim Report

27. (c) 147 147 * (d) 3,756 5,363 27 27 59 3,842 5,390 59

28. (a) 12 (b) 29. SODX Co., Ltd.SODX SODX 244.017.1 SODX SODX SODX 30. 60 PuraPharm Corporation 2017 Limited 2017 Interim Report